임상시험

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

NCT: NCT06965504 · NOT_YET_RECRUITING

NCT IDNCT06965504

상태NOT_YET_RECRUITING

시작일2026-09-01

완료2029-06-01

SponsorAbiomed Inc. (INDUSTRY)

First posted2025-05-11

Last updated2026-09-10

간략 요약

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.